Background No effective treatments for coronavirus disease 2019 (COVID-19) exist. We
aimed to determine whether early treatment with hydroxychloroquine (HCQ) would be …

Background Scarce data are available on what variables affect the risk of transmission of
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the development of …

Background Current strategies for preventing severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection are limited to nonpharmacologic interventions. …

Objective To develop a proposal for a 2-year mortality prognostic approach for patients with
advanced chronic conditions based on the palliative care need (PCN) items of the …

Background The optimization of the use of β-lactam antibiotics (BLA) via prolonged infusions
in life-threatening complications such as febrile neutropenia (FN) is still controversial. This …

Contamination of the preservation fluid (PF) used for donated organs is a potential source of
post-transplant infection. However, the information on this issue is scarce. We therefore …

The natural history of coronavirus disease 2019 (COVID-19) has yet to be fully described.
Here, we use patient-level data from the Information System for Research in Primary Care (…

Background We aimed to determine whether daptomycin plus fosfomycin provides higher
treatment success than daptomycin alone for methicillin-resistant Staphylococcus aureus (…

Background The objective of the present study was to compare three different sampling and
questionnaire administration methods used in the international KIDSCREEN study in terms …

Bisphosphonates are the first‐line treatment for preventing fractures in osteoporosis patients.
However, their use is contraindicated or to be used with caution in chronic kidney disease (…